Key Facts on AstraZeneca

• Formed April 1999, by a merger between Astra AB (Sweden) and Zeneca PLC (U.K.).
• Canadian president and CEO: Elaine Campbell.

Employees

• Over 800 employees in Canada.
• The majority of our people work at our high-tech facility in Mississauga, Ontario, headquarters for our packaging, clinical research, sales, marketing and distribution business.
• More than 125 scientists are employed at our state-of-the-art basic research facility in Montreal.

Key Therapeutic Areas

• Cardiovascular
• Gastrointestinal
• Oncology
• Respiratory
• Neuroscience
• Infection

Sponsorship of Research Chairs & Fellowships

In addition to many research grants and awards, AstraZeneca Canada is proud to sponsor a number of research chairs & fellowships at many of Canada's leading universities.

• AstraZeneca Chair in Organic Synthesis - University of Toronto
• Chair in Biotechnology - University of Toronto at Mississauga
• Asthma Chair - University of Alberta
• Moran Campbell Chair in Respirology - McMaster University
• Chair in Cardiovascular Research - McMaster University
• Chair in Respiratory Disease Management - University of Montréal
• AstraZeneca Chair in Schizophrenia - University of Saskatchewan
• AstraZeneca/Firestone Chair in Respiratory - McMaster University
• Richard Hunt/AstraZeneca Chair in Gastroenterology and Pharmacology - McMaster University
• Gerry McDole Research Fellowship - University of Manitoba

• An Imagine Caring Company. AstraZeneca made a commitment to Imagine’s corporate giving standards, donating a minimum of one per cent of pre-tax profits to community organizations and encouraging employee volunteering.
• Through AstraZeneca’s internal Side by Side program, the company acknowledges and financially supports the charitable organizations with which our employees are personally involved.